Spyre Therapeutics Stock Price History
| SYRE Stock | 18.15 0.25 1.36% |
Below is the normalized historical share price chart for Spyre Therapeutics extending back to April 07, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spyre Therapeutics stands at 18.15, as last reported on the 20th of March, with the highest price reaching 18.65 and the lowest price hitting 18.03 during the day.
If you're considering investing in Spyre Stock, it is important to understand the factors that can impact its price. Spyre Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.11, which indicates the firm had a -0.11 % return per unit of risk over the last 3 months. Spyre Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spyre Therapeutics' Coefficient Of Variation of (815.61), risk adjusted performance of (0.10), and Variance of 14.91 to confirm the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 543.7 M. The current year's Common Stock Shares Outstanding is expected to grow to about 393.1 M. At present, Spyre Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 168.48, whereas Price Book Value Ratio is forecasted to decline to 10.84. Spyre Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of April 2016 | 200 Day MA 26.8378 | 50 Day MA 21.158 | Beta 2.993 |
Spyre |
Sharpe Ratio = -0.106
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SYRE |
Estimated Market Risk
| 3.67 actual daily | 32 68% of assets are more volatile |
Expected Return
| -0.39 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spyre Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spyre Therapeutics by adding Spyre Therapeutics to a well-diversified portfolio.
Price Book 3.0629 | Enterprise Value Ebitda (7.96) | Price Sales 650.2181 | Shares Float 46.6 M | Wall Street Target Price 55.1111 |
Spyre Therapeutics Stock Price History Chart
There are several ways to analyze Spyre Stock price data. The simplest method is using a basic Spyre candlestick price chart, which shows Spyre Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 6, 2025 | 24.42 |
| Lowest Price | March 18, 2025 | 17.91 |
Spyre Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of Spyre Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Spyre Stock. It can be used to describe the percentage change in the price of Spyre Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Spyre Stock.| Spyre Therapeutics Price Rate Of Daily Change | 0.99 | |
| Spyre Therapeutics Price Action Indicator | (0.32) | |
| Spyre Therapeutics Accumulation Distribution | 9,708 | |
| Spyre Therapeutics Price Daily Balance Of Power | (0.40) |
Spyre Therapeutics March 20, 2025 Stock Price Analysis
Spyre Stock Price History Data
The price series of Spyre Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 8.53 with a coefficient of variation of 9.69. The price distribution for the period has arithmetic mean of 21.83. The median price for the last 90 days is 22.28. The company completed stock split (1:25) on 8th of September 2023.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 18.03 | 18.65 | 18.03 | 18.15 | 292,028 | |
| 03/19/2025 | 17.89 | 18.82 | 17.79 | 18.40 | 496,214 | |
| 03/18/2025 | 19.00 | 19.00 | 17.86 | 17.91 | 381,314 | |
| 03/17/2025 | 18.68 | 18.89 | 18.13 | 18.54 | 485,117 | |
| 03/14/2025 | 18.24 | 18.99 | 17.86 | 18.04 | 389,497 | |
| 03/13/2025 | 18.74 | 19.00 | 17.50 | 18.03 | 337,669 | |
| 03/12/2025 | 18.68 | 19.44 | 18.39 | 18.88 | 459,519 | |
| 03/11/2025 | 19.58 | 19.58 | 17.25 | 18.56 | 874,444 | |
| 03/10/2025 | 18.98 | 19.73 | 18.18 | 18.65 | 642,832 | |
| 03/07/2025 | 20.34 | 21.03 | 19.43 | 19.49 | 1,016,776 | |
| 03/06/2025 | 19.27 | 20.57 | 18.72 | 20.50 | 946,583 | |
| 03/05/2025 | 18.32 | 19.59 | 18.04 | 19.47 | 668,373 | |
| 03/04/2025 | 17.81 | 18.59 | 17.24 | 18.22 | 725,079 | |
| 03/03/2025 | 20.00 | 20.00 | 17.56 | 17.94 | 526,582 | |
| 02/28/2025 | 18.69 | 19.98 | 18.39 | 19.70 | 651,522 | |
| 02/27/2025 | 19.00 | 19.80 | 18.26 | 18.37 | 881,118 | |
| 02/26/2025 | 20.96 | 21.50 | 18.81 | 19.00 | 780,000 | |
| 02/25/2025 | 21.49 | 21.50 | 19.83 | 20.65 | 686,185 | |
| 02/24/2025 | 21.48 | 21.93 | 20.56 | 21.26 | 612,815 | |
| 02/21/2025 | 22.56 | 22.86 | 20.29 | 21.29 | 790,123 | |
| 02/20/2025 | 22.18 | 23.04 | 21.63 | 22.41 | 318,393 | |
| 02/19/2025 | 21.93 | 22.55 | 21.92 | 22.37 | 263,200 | |
| 02/18/2025 | 23.04 | 23.60 | 21.61 | 22.07 | 629,187 | |
| 02/14/2025 | 23.05 | 23.19 | 22.43 | 22.92 | 416,061 | |
| 02/13/2025 | 23.59 | 23.75 | 22.57 | 22.68 | 495,341 | |
| 02/12/2025 | 21.63 | 23.35 | 21.13 | 23.27 | 467,900 | |
| 02/11/2025 | 22.35 | 22.75 | 21.90 | 22.15 | 848,007 | |
| 02/10/2025 | 22.87 | 23.00 | 22.11 | 22.75 | 709,220 | |
| 02/07/2025 | 23.72 | 24.39 | 22.44 | 22.65 | 682,827 | |
| 02/06/2025 | 23.54 | 24.35 | 23.52 | 23.86 | 473,136 | |
| 02/05/2025 | 23.78 | 24.83 | 23.41 | 23.56 | 353,419 | |
| 02/04/2025 | 22.75 | 23.84 | 22.60 | 23.70 | 645,300 | |
| 02/03/2025 | 22.04 | 23.68 | 21.67 | 22.90 | 508,600 | |
| 01/31/2025 | 22.50 | 23.59 | 22.25 | 22.99 | 557,500 | |
| 01/30/2025 | 22.13 | 22.74 | 21.79 | 22.27 | 1,243,000 | |
| 01/29/2025 | 21.66 | 22.18 | 21.35 | 21.90 | 330,100 | |
| 01/28/2025 | 20.77 | 22.00 | 20.25 | 21.79 | 533,000 | |
| 01/27/2025 | 21.31 | 22.81 | 20.66 | 20.82 | 501,600 | |
| 01/24/2025 | 21.85 | 22.44 | 21.00 | 21.60 | 437,200 | |
| 01/23/2025 | 21.64 | 22.05 | 21.01 | 21.81 | 532,132 | |
| 01/22/2025 | 22.69 | 22.81 | 21.59 | 21.82 | 651,496 | |
| 01/21/2025 | 21.00 | 22.82 | 20.97 | 22.28 | 692,674 | |
| 01/17/2025 | 20.96 | 21.24 | 20.33 | 20.62 | 607,576 | |
| 01/16/2025 | 21.84 | 22.11 | 20.39 | 20.55 | 715,277 | |
| 01/15/2025 | 21.89 | 22.49 | 21.05 | 21.66 | 513,870 | |
| 01/14/2025 | 21.75 | 21.97 | 20.36 | 20.80 | 489,686 | |
| 01/13/2025 | 23.00 | 23.00 | 20.55 | 21.55 | 715,634 | |
| 01/10/2025 | 23.29 | 23.76 | 21.60 | 22.46 | 687,236 | |
| 01/08/2025 | 24.21 | 24.52 | 23.77 | 24.02 | 484,641 | |
| 01/07/2025 | 24.60 | 26.01 | 24.05 | 24.35 | 1,192,779 | |
| 01/06/2025 | 24.66 | 25.40 | 24.25 | 24.42 | 306,316 | |
| 01/03/2025 | 23.66 | 24.83 | 23.66 | 24.35 | 214,933 | |
| 01/02/2025 | 23.60 | 24.45 | 23.33 | 23.85 | 467,777 | |
| 12/31/2024 | 22.85 | 24.05 | 22.63 | 23.28 | 556,166 | |
| 12/30/2024 | 23.35 | 23.44 | 22.37 | 22.54 | 359,557 | |
| 12/27/2024 | 24.00 | 24.34 | 23.18 | 23.67 | 315,650 | |
| 12/26/2024 | 23.13 | 24.08 | 22.95 | 24.07 | 285,039 | |
| 12/24/2024 | 23.58 | 23.64 | 22.73 | 23.34 | 231,281 | |
| 12/23/2024 | 23.74 | 23.85 | 22.79 | 23.59 | 302,819 | |
| 12/20/2024 | 22.90 | 24.88 | 22.62 | 23.86 | 1,261,050 | |
| 12/19/2024 | 23.56 | 23.86 | 22.59 | 23.13 | 446,610 |
About Spyre Therapeutics Stock history
Spyre Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spyre is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spyre Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spyre Therapeutics stock prices may prove useful in developing a viable investing in Spyre Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 374.4 M | 393.1 M |
Spyre Therapeutics Quarterly Net Working Capital |
|
Spyre Therapeutics Stock Technical Analysis
Spyre Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Spyre Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Spyre Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spyre Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spyre to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.10) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (0.35) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Spyre Stock analysis
When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |